These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 2875280)

  • 1. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
    Meade TW; Mellows S; Brozovic M; Miller GJ; Chakrabarti RR; North WR; Haines AP; Stirling Y; Imeson JD; Thompson SG
    Lancet; 1986 Sep; 2(8506):533-7. PubMed ID: 2875280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal status and haemostatic variables.
    Meade TW; Haines AP; Imeson JD; Stirling Y; Thompson SG
    Lancet; 1983 Jan; 1(8314-5):22-4. PubMed ID: 6129369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemostatic function and cardiovascular death: early results of a prospective study.
    Meade TW; North WR; Chakrabarti R; Stirling Y; Haines AP; Thompson SG; Brozovié M
    Lancet; 1980 May; 1(8177):1050-4. PubMed ID: 6103391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.
    Meade TW; Imeson J; Stirling Y
    Lancet; 1987 Oct; 2(8566):986-8. PubMed ID: 2889958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).
    De Stavola BL; Meade TW
    J Thromb Haemost; 2007 Mar; 5(3):461-71. PubMed ID: 17137470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factor VII and the risk of coronary heart disease in healthy men.
    Junker R; Heinrich J; Schulte H; van de Loo J; Assmann G
    Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1539-44. PubMed ID: 9301633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group.
    Meade TW; Stirling Y; Thompson SG; Vickers MV; Woolf L; Ajdukiewicz AB; Stewart G; Davidson JF; Walker ID; Douglas AS
    Int J Epidemiol; 1986 Sep; 15(3):331-6. PubMed ID: 3095254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercoagulability and ischaemic heart disease.
    Meade TW
    Blood Rev; 1987 Mar; 1(1):2-8. PubMed ID: 3332083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study.
    Baker IA; Eastham R; Elwood PC; Etherington M; O'Brien JR; Sweetnam PM
    Br Heart J; 1982 May; 47(5):490-4. PubMed ID: 7073911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.
    Meade TW; Ruddock V; Stirling Y; Chakrabarti R; Miller GJ
    Lancet; 1993 Oct; 342(8879):1076-9. PubMed ID: 8105310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies.
    Yarnell JW; Patterson CC; Sweetnam PM; Lowe GD
    Eur Heart J; 2004 Jun; 25(12):1049-56. PubMed ID: 15191776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.
    Miller GJ; Bauer KA; Barzegar S; Cooper JA; Rosenberg RD
    Thromb Haemost; 1996 May; 75(5):767-71. PubMed ID: 8725721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study.
    Salomaa V; Rasi V; Pekkanen J; Vahtera E; Jauhiainen M; Vartiainen E; Myllylä G; Ehnholm C
    Eur Heart J; 1994 Oct; 15(10):1293-9. PubMed ID: 7821305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.
    Yarnell JW; Baker IA; Sweetnam PM; Bainton D; O'Brien JR; Whitehead PJ; Elwood PC
    Circulation; 1991 Mar; 83(3):836-44. PubMed ID: 1999035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemostatic factors and ischaemic heart disease. The Caerphilly study.
    Yarnell JW; Sweetnam PM; Elwood PC; Eastham R; Gilmour RA; O'Brien JR; Etherington MD
    Br Heart J; 1985 May; 53(5):483-7. PubMed ID: 3994861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen, factor VII clotting activity and coronary artery disease severity.
    Broadhurst P; Kelleher C; Hughes L; Imeson JD; Raftery EB
    Atherosclerosis; 1990 Dec; 85(2-3):169-73. PubMed ID: 2102080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fibrinogen level is not elevated in young adults from families with premature ischemic heart disease.
    Hoffman CJ; Burns P; Lawson WE; Katz JP; Miller RH; Hultin MB
    Arterioscler Thromb; 1993 Jun; 13(6):800-3. PubMed ID: 8499399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD).
    Meade TW; Cooper JA; Miller GJ
    Thromb Haemost; 1997 Aug; 78(2):926-9. PubMed ID: 9268196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostasis and cardiovascular risk. The British and European experience.
    Miller GJ
    Arch Pathol Lab Med; 1992 Dec; 116(12):1318-21. PubMed ID: 1456878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.